“Great companies were never built by conservative leaders.
Great companies were built by risk-takers.”
Deeply ingrained in Curaleaf’s DNA is the ability to navigate the unknown ahead of opportunities.
Timing these events is nearly impossible, but having the foresight and strategic resources in place when the opportunity strikes can change the game.
For visionaries like Boris Jordan, being early in markets like Germany can be challenging for everyone to see until recent developments materialize.
The US and European cannabis markets operate very differently, and Curaleaf is in a prime position to secure an untapped market share twice the size of the US.
This week, we sit down with Boris Jordan to discuss the following:
• Unique Market Differences: Europe vs US
• Educating Institutional Investors: What does that conversation look like inside the room?
• Breakdown of the German Market, Hint toward Asia
• And so much more
00:00 Welcome to The Dime: A Special Episode with Boris Jordan
00:46 Curaleaf’s Global Cannabis Empire: Origins and Growth
01:36 The Catalysts Behind Curaleaf’s Explosive Growth
05:58 Navigating the Complex Cannabis Markets: US vs Europe
09:06 Curaleaf’s Strategic Expansion and Lessons Learned
18:44 The Future of Cannabis: Regulatory Challenges and Opportunities
23:06 Innovations in Cannabis: Telemedicine and Product Favorites
26:10 Building Global Cannabis Brands: Strategy and Challenges
28:47 Building a Moat in the Cannabis Industry
29:42 Expanding Horizons: Targeting New European Markets
31:51 Evaluating New Markets: Strategy and Considerations
33:55 Educating Institutional Investors: A New Frontier
40:01 The New York Market: Challenges and Opportunities
47:51 Rapid Fire Round: Insights and Predictions
53:33 Facing the Future: Competing with Big Pharma and Tobacco
About Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. In the United States, our brands are sold in 17 states with operations encompassing 147 dispensaries and employing more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.
Follow us: Our Links.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain
The Dime is a top 5% most shared global podcast
The Dime is a top 50 Cannabis Podcast
Sign up for our playbook here:
🎥 YouTube: The Dime
📸 Instagram: The Dime
source
